INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K (Form 6-K)

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

Change in Director Compensation

As previously reported, on October 15, 2025, in connection with Dr. Yunhao Chen's appointment as an independent director of the Board of Mega Matrix Inc. (the "Company"), a member of the Compensation Committee and Audit Committee, and chairperson of the Audit Committee, the Company entered into a standard independent director agreement with Dr. Yunhao Chen (the "Director Agreement"), pursuant to which Dr. Chen is entitled to receive annual cash compensation of $36,000 during her period of service, and a grant of 24,000 restricted share units, which vests quarterly commencing on December 31, 2025. An award agreement was entered into the same day to set forth terms and conditions of the 24,000 restricted share units ("Award Agreement"). As of the date hereof, 6,000 restricted shares units have vested and 18,000 restricted share units remain unvested under the Award Agreement ("Unvested Shares").

At the request of Dr. Chen and upon the Board of Directors' approval, on March 16, 2026, the Company entered into an Amendment to the Director Agreement with Dr. Chen (the "Amendment") to (i) terminate the Award Agreement and cancel the Unvested Shares in their entirety; and (ii) amend the Director Agreement to adjust her monthly cash compensation from $3,000.00 to $5,000.00 (the "Monthly Fee"). The Monthly Fee shall be effective retroactively to January 1, 2026, and payable in accordance with the Company's standard payroll practices.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 to this Report on Form 6-K and is incorporated herein by reference.

Incorporation by Reference

This report and the exhibit shall be deemed to be incorporated by reference in the registration statements on Form S-8 (File No. 333-277227), Form F-3 (File No. 333-283739), Form S-8 (File No. 333-289715), and Form F-3 (File No. 333-290026), each as filed with the Securities and Exchange Commission, to the extent not superseded by documents or reports subsequently filed.

EXHIBIT INDEX